The group’s principle activity is to provide treatment for hormonal and metabolic disorders including type 1 and 2 diabetes, gestational diabetes, thyroid disease, osteoporosis, lipid disorders (high cholesterol), pituitary/adrenal gland problems and menstrual disorders. The group operates from United States.
